Dianthus Therapeutics (DNTH) Assets (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Assets of $530.9 million for Q4 2025, up 41.95% year-over-year from $374.0 million in Q4 2024, and down 8.06% quarter-over-quarter from $577.4 million in Q3 2025.
Dianthus Therapeutics (DNTH) Assets (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Assets history runs 9 years deep, the most recent figure standing at $530.9 million for Q4 2025.
- In Q4 2025, Assets rose 41.95% year-over-year to $530.9 million; the TTM figure through Dec 2025 stood at $530.9 million (up 41.95% YoY), while the FY2025 annual figure was $530.9 million, up 41.95% from the prior year.
- Assets for Q4 2025 stood at $530.9 million, down from $577.4 million in the prior quarter.
- The five-year high for Assets was $577.4 million in Q3 2025, with the low at $78.6 million in Q2 2023.
- The 5-year median for Assets is $200.3 million (2021), against an average of $258.7 million.
- The sharpest annual moves came in 2023 and 2024: Assets plunged 57.07% in 2023, then surged 369.19% in 2024.
- Dianthus Therapeutics' Assets stood at $189.9 million in 2021, then slumped by 56.24% to $83.1 million in 2022, then jumped by 115.86% to $179.4 million in 2023, then soared by 108.47% to $374.0 million in 2024, then jumped by 41.95% to $530.9 million in 2025.
- Business Quant data shows DNTH's Assets at $530.9 million in Q4 2025, $577.4 million in Q3 2025, and $326.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | 530.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 530.92 Mn |
| Sep 30, 2025 | 577.45 Mn |
| Jun 30, 2025 | 326.08 Mn |
| Mar 31, 2025 | 348.58 Mn |
| Dec 31, 2024 | 374.01 Mn |
| Sep 30, 2024 | 354.25 Mn |
| Jun 30, 2024 | 368.96 Mn |
| Mar 31, 2024 | 382.46 Mn |
| Dec 31, 2023 | 179.41 Mn |
| Sep 30, 2023 | 192.46 Mn |
| Jun 30, 2023 | 78.64 Mn |
| Mar 31, 2023 | 83.44 Mn |
| Dec 31, 2022 | 83.11 Mn |
| Sep 30, 2022 | 164.12 Mn |
| Jun 30, 2022 | 175.12 Mn |
| Mar 31, 2022 | 194.39 Mn |
| Dec 31, 2021 | 189.93 Mn |
| Sep 30, 2021 | 206.24 Mn |
| Jun 30, 2021 | 220.38 Mn |
| Mar 31, 2021 | 144.62 Mn |